Costamare Bulkers Holdings Limited CMDB Q1 2026 Earnings Strong EPS Amid Flat Revenue as Industry Tailwinds Support Margins Nyxoah NYXH Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Sleep Apnea Pipeline Fulcrum Therapeutics FULC Q1 2026 Earnings NarrowerthanExpected Loss Despite Mild Stock Dip ZEPP Q3 2025 Earnings Narrowing Loss Without Revenue Disclosure Krystal Biotech KRYS Q1 2026 Earnings Strong Earnings Beat Amidst Modest Stock Decline OVID Q1 2026 Earnings Narrower Loss and No Revenue Mark a Quiet Quarter for the Biotech